Despite new medication, cystic fibrosis often leads to permanent lung damage. Working with an international team, researchers ...

Despite new medication, cystic fibrosis often leads to permanent lung damage. Working with an international team, researchers from the Technical University of Munich (TUM) have discovered that the ...

Despite new medication, cystic fibrosis often leads to permanent lung damage. Working with an international team, researchers from the Technical University of Munich (TUM) have discovered that the ...

The Massachusetts-based biotech plans to use the funds to push its candidates into mid-stage clinical trials in a space ...

Sionna Therapeutics is eyeing a $156 million IPO as the cystic-fibrosis-focused biotech looks to take its lead candidate into ...

Lives are "needlessly being put at risk" in parts of Lancashire and Greater Manchester due to a shortage of defibrillators, a charity has warned. The British Heart Foundation (BFH) and Sky Bet ...

Patients aged 6 to 11 years with cystic fibrosis receiving 24-week once-daily vanzacaftor/tezacaftor/deutivacaftor generally tolerated it well, according to data published in The Lancet Respiratory ...

Sionna Therapeutics aims to raise $100 million in an IPO for cystic fibrosis drugs, backed by venture capital, targeting a ...

In December, the FDA approved Vertex’s vanzacaftor, tezacaftor and deutivacaftor (Alyftrek) for the treatment of cystic fibrosis in patients with at least one F508del mutation or another ...

The Seafarers Hospital Society, a UK charity, said free defibrillators and first aid kits were being provided to Jersey fishers Jersey and Guernsey fishers are set to receive free defibrillators ...

A Co Derry man says it is “positive” news that more defibrillators have been registered on a UK-wide network after his life was saved by one of the devices. John Deery (64) from Eglinton ...

Collaborative Discovery Programme (CDP) funding introduced by the Cystic Fibrosis Antimicrobial Resistance (CF AMR) Syndicate. The funding of up to £500,000 is provided by LifeArc, a medical research ...